Ondine Biomedical

Risk score

57
Large logo of Ondine Biomedical

Headquarters

Flag of CanadaCanada

Our primary focus is on the advancement and commercialization of innovative antimicrobial treatments that cater to important patient requirements, are eco-friendly, offer significant public health advantages, are easily deployable, and are cost-effective compared to the infections they combat. Taking the lead in pioneering photodisinfection-based therapies to prevent and manage a wide range of infections, including those induced by drug-resistant bacteria.